ORamaVR (www.oramavr.com) is a deep technology, spatial computing startup, innovating the field of med-ed-tech Virtual Reality (VR) training simulation authoring platforms. Our technologies are based on state-of-the-art research by world-renowned scientists team members. This research is turned into a novel, symbiotic VR authoring and simulation platform by our top engineers, medical professionals and business developers. ORamaVR was founded in 2016 and received initial €575K pre-seed financing from the VC PJ TECH CATALYST FUND in Greece. The company has moved its HQ to Geneva, Switzerland upon strategic partners’ demand. ORamaVR is adopted by the USC Keck School of Medicine, Los Angeles, NYU Langone Medical centre in New York, the University of Geneva and the Inselspital Hospital system in Switzerland, FORTH and the University of Athens in Greece and recently Western Governors University, Fayetteville State University and the University of Michigan in USA. Medacta International, a leading Swiss medical implant manufacturer expressed high interest to collaborate intensively with ORamaVR. ORamaVR has been awarded in 2020 an Epic Games Mega-Grant, in 2019 the Augmented World Expo (AWE) Auggie award for “Best Societal Impact” and the prestigious FARE award, from the American Association of Hip and Knee Surgeons (AAHKS) in 2018. ORamaVR has attracted more than €1.3M in R&D grants and awards up to date. In 2020 ORamaVR concluded a €370K bridge round led by HTC Vive, a leader in enterprise virtual reality.
Learn more about this company on Crunchbase.